News  Donate!

Ask-the-Expert: Genetics of DM

Ask-the-Expert: Genetics of DM

Friday, August 15th
3:00 PM Pacific / 6:00 PM Eastern
 

Register Now! 
 

Thank you to our 2025 Community Education Webinar Series Sponsors, Avidity Biosciences and Dyne Therapeutics!

Join us for our upcoming Ask-the-Expert webinar "Genetics of DM: Understanding Inheritance, Expansions, and Research" This webinar will feature MDF's Chief Scientific Officer, Andy Rohrwasser, PhD, MBA.  

Don't miss this opportunity to learn from a leading expert and gain access to essential resources that can help improve the quality of life for those living with myotonic dystrophy. There will be a Q&A session at the end, allowing participants to ask Dr. Dixon their most pressing questions about mental health and DM. Click here to register for Ask the Expert: Genetics of Myotonic Dystrophy! >>>

Register once and you can join any of our 2025 Ask the Expert webinars! Join us at our next Ask the Expert webinar! Click here to find all our upcoming Ask the Expert dates and previously recorded sessions. >>>

Questions or comments? Contact MDF at 415-800-7777 or at info@myotonic.org.

About the Presenter

Andy Rohrwasser, PhD, MBA

Andy’s domain expertise and passion are rare diseases, genetics and genomics, and newborn screening. Andy implemented gene agnostic, next-generation sequencing as a universal second tier newborn screening modality. Under his leadership, Utah was the first state in the US to implement population wide screening for Spinal Muscular Atrophy (SMA). 

Andy serves as an adjunct associate professor in pediatric neurology at the University of Utah, where he also received his PhD in Human Genetics and an MBA. As the laboratory director for the Utah Public Health Laboratory he oversaw multiple operational units with diverse regulatory requirements, customer bases and stakeholders. 

Andy was the principal investigator of multiple, multi-year research projects funded by HRSA, CMS, APHL, and CDC. He serves on multiple advisory committees for the CDC and APHL, and he has served as reviewer for NIH study sections, and multiple scientific journals as well as a member of the Utah IRB.

Date(s)